NurExone Biologic Extends Spinal Cord Injury Therapy Portfolio With New RNA Sequences Promoting Healing and Regeneration
November 29, 2023 08:30 ET
|
NurExone Biologic Inc
NurExone Biologic expands its portfolio of products to address spinal cord injuries & neuron regeneration in CNS indications
NurExone Biologic to Present Exosome-Based Therapy for Spinal Cord Injury in Regenerative Medicine Session at Upcoming Extracellular Vesicles Forum
October 05, 2023 08:30 ET
|
NurExone Biologic Inc
NurExone Biologic will present at the EVs Forum in Cambridge presents advances in exosome therapy for spinal cord injuries, highlighting ExoPTEN potential
Exosomes Market Size to Surpass USD 2,707.8 million by 2032 at Sustained CAGR of 34.2% - Market.us Study
May 08, 2023 09:29 ET
|
Market.Us
New York, May 08, 2023 (GLOBE NEWSWIRE) -- The exosomes market size is projected to surpass around USD 2,707.8 Million by 2032 and it is poised to reach a CAGR of 34.2% from 2023 to 2032. The global...
Exosome Technologies Market Value to Reach USD 343.5 Mn by 2031, rising at a CAGR of 24.8%: TMR Study
May 05, 2023 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 05, 2023 (GLOBE NEWSWIRE) -- The global exosome technologies market was valued at USD 47.3 Mn in 2022 and is projected to exceed USD 343.5 Mn by 2031. ...
NurExone Biologic Reports Additional Positive Preclinical Trial Outcomes with ExoPTEN: 75% of Paralyzed Rats Show Recovery after Acute Spinal Cord Injury Study
March 20, 2023 07:58 ET
|
NurExone
TORONTO and TEL AVIV, Israel, March 20, 2023 (GLOBE NEWSWIRE) -- Toronto and Tel Aviv, March 20, 2023 - Biopharmaceutical firm NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (“NurExone” or...
Global Acellular Therapy Market Size Was Valued at $8.451 Billion in 2022 and Is Projected to Surpass Around $32.61 Billion Mark by 2030, Growing at a CAGR of 16.21%
March 16, 2023 07:02 ET
|
Zion Market Research
Washington, DC, March 16, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Acellular Therapy Market By Disease (Parkinson’s, Alzeihmer’s, Chronic Wounds,...
US Exosome Research Products Market Is Projected To Reach US$ 1.9 Billion, Advancing Rapidly At A CAGR Of 20.8% - Fact.MR Report
January 11, 2023 06:30 ET
|
FACT.MR
Rockville, Jan. 11, 2023 (GLOBE NEWSWIRE) -- As per a recently published industry report by Fact.MR, a provider of market research and competitive intelligence, the global exosome research products...
The exosome therapeutics market is projected to grow at an annualized rate of 41%, claims Roots Analysis
December 13, 2022 09:00 ET
|
Roots Analysis
London, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Exosome Therapeutics Market, 2022-2040” report to its list of offerings. With the advancements in...
Liquid Biopsy Market Size worth $8.12 Bn Globally by 2027 at 9.9% CAGR Says, The Insight Partners
July 26, 2022 07:34 ET
|
The Insight Partners
New York, July 26, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Liquid Biopsy Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product &...
Exosomes Market Size [2022-2029] | Industry Trends, Share, Growth, SWOT Analysis, Market Drivers, Restraints, Opportunities, And Key Developments
July 20, 2022 05:12 ET
|
Fortune Business Insights
Pune, India, July 20, 2022 (GLOBE NEWSWIRE) -- The global “Exosomes Market Size” is expected to gain momentum owing to the rising prevalence of cancer during the forecast period. This information is...